Jeff Knight files to sell 44,925 shares

Jeff Knight reports proposed dispositions of Common Stock and recent 10b5-1 sales.

Rhea-AI Filing Summary

Jeff Knight reports proposed dispositions of Common Stock and recent 10b5-1 sales. The filing lists 44,925 shares tied to an Exercise of Stock Options with a proposed sale date of 07/02/2026 and 2,495 Restricted Stock Units dated 03/15/2025. The excerpt also shows 10b5-1 sales totaling 120,982 shares across 04/08/2026–05/04/2026 with proceeds reported in the filing.

Insights

Securities Compliance Counsel

Filing documents planned option exercise and resale plus prior 10b5-1 sales.

The filing records a proposed disposition of 44,925 shares from an Exercise of Stock Options on 07/02/2026 and 2,495 RSUs dated 03/15/2025. The excerpt also itemizes multiple 10b5-1 sales during April–May 2026.

These entries are routine disclosures under resale/affiliate rules; timing and execution mechanics are governed by the stated dates and any pre-arranged 10b5-1 plan. Subsequent filings will show actual settlement details and cash-flow recipients.

Key Figures

Proposed sale (options): 44,925 shares RSUs listed: 2,495 shares 10b5-1 sales aggregate (excerpt): 120,982 shares +3 more

6 metrics

Proposed sale (options) 44,925 shares Exercise of Stock Options on <date>07/02/2026</date>

RSUs listed 2,495 shares Restricted Stock Units dated <date>03/15/2025</date>

10b5-1 sales aggregate (excerpt) 120,982 shares Trades from <date>04/08/2026</date> to <date>05/04/2026</date>

Proceeds: 04/08/2026 trade <money>$3,414,701.10</money> <date>04/08/2026</date> sale of 85,163 shares

Proceeds: 04/14/2026 trade <money>$839,061.85</money> <date>04/14/2026</date> sale of 20,900 shares

Proceeds: 05/04/2026 trade <money>$380,480.92</money> <date>05/04/2026</date> sale of 9,485 shares

Key Terms

10b5-1, Restricted Stock Units, Exercise of Stock Options

3 terms

10b5-1 regulatory

"10b5-1 Sales for JEFF KNIGHT 6055 Lusk Boulevard"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Restricted Stock Units financial

"Restricted Stock Units | Issuer | 2495 | 03/15/2025"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Exercise of Stock Options financial

"Exercise of Stock Options | Issuer | 44925 | 07/02/2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 from CRNX show about Jeff Knight's planned sales?

The Form 144 lists a proposed sale of 44,925 shares from an option exercise dated 07/02/2026 and 2,495 RSUs dated 03/15/2025. It also lists prior 10b5-1 sales in April–May 2026.

How many shares did Jeff Knight sell under 10b5-1 in the past three months?

The excerpt reports 10b5-1 sales totaling 120,982 shares across four trades dated 04/08/2026 to 05/04/2026, with proceeds shown per trade in the filing.

What proceeds are reported for the recent 10b5-1 sales on the Form 144?

The filing shows proceeds for individual trades: $3,414,701.10 (04/08/2026), $177,438.04 (04/13/2026), $839,061.85 (04/14/2026), and $380,480.92 (05/04/2026), as disclosed in the excerpt.

Does the Form 144 specify who will receive the cash from the proposed sales?

The excerpt identifies the transactions as dispositions tied to an option exercise and RSUs but does not state the cash-flow recipient explicitly within the provided lines.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 04:31 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001881007
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Crinetics Pharmaceuticals, Inc.
SEC File Number	001-38583
Address of Issuer	6055 Lusk Boulevard San Diego CALIFORNIA 92121
Phone	8584506464
Name of Person for Whose Account the Securities are To Be Sold	JEFF KNIGHT
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	47420	1834205.60	105440208	07/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/02/2026	Exercise of Stock Options	Issuer			44925	07/02/2026	Cash
Common	03/15/2025	Restricted Stock Units	Issuer			2495	03/15/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JEFF KNIGHT 6055 Lusk Boulevard San Diego CA 92121	Common	05/04/2026	9485	380480.92
10b5-1 Sales for JEFF KNIGHT 6055 Lusk Boulevard San Diego CA 92121	Common	04/14/2026	20900	839061.85
10b5-1 Sales for JEFF KNIGHT 6055 Lusk Boulevard San Diego CA 92121	Common	04/13/2026	4434	177438.04
10b5-1 Sales for JEFF KNIGHT 6055 Lusk Boulevard San Diego CA 92121	Common	04/08/2026	85163	3414701.10

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	07/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jeff Knight
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)